<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of this study was to prospectively evaluate a new high-power <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation system (hp-APC) in therapeutic gastrointestinal (GI) endoscopy </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: From February to June 2005, 216 patients (167 M (77.3%), mean age 66 years) underwent treatment with hp-APC in a total of 275 sessions </plain></SENT>
<SENT sid="2" pm="."><plain>Main indications were additive ablation therapy in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, palliative treatment of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, <z:mp ids='MP_0003299'>gastric polyps</z:mp>/<z:mp ids='MP_0002038'>carcinomas</z:mp>, <z:e sem="disease" ids="C0267370,C0085411" disease_type="Disease or Syndrome" abbrv="">angiodysplasias</z:e>, <z:e sem="disease" ids="C0085232" disease_type="Disease or Syndrome" abbrv="">Zenker's diverticula</z:e>, and duodenal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>The new hp-APC device (VIO 300 D with APC 2) was used (15-120 W) in upper GI endoscopy, push-enteroscopy, and double-balloon enteroscopy </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The mean number of treatment sessions required was 1.7 (1-5) </plain></SENT>
<SENT sid="5" pm="."><plain>For palliative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> ablation in the esophagus, the number of sessions was 2.3 (1-5) </plain></SENT>
<SENT sid="6" pm="."><plain>Minor complications (pain, <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, neuromuscular irritation, asymptomatic gas accumulation in the intestinal wall) were observed in 29/216 patients (13.4%) </plain></SENT>
<SENT sid="7" pm="."><plain>Major complications (<z:mpath ids='MPATH_81'>perforation</z:mpath>, stenosis occurred) in 2 patients (0.9%) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Hp-APC appears to be safe and effective in the treatment of various GI condition using different types of endoscopes including double-balloon enteroscopy </plain></SENT>
<SENT sid="9" pm="."><plain>Because of the low number of treatment sessions required, hp-APC could be used as an alternative to Nd:YAG laser treatment in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> debulking </plain></SENT>
</text></document>